[laughs]

And yeah, I, I guess our mission is to leverage as many of the new, different technologies that we can to understand disease and make therapies, and that could be gene editing, as, you know, what we're focusing on mostly these days, uh, but it can be, you know, classical gene augmentation.

It can be, you know, a variety of different, uh, methodologies.

It's just incrementally trying to think of different ways to maybe help patients.

And, you know, one of the things that we, we mostly use in the lab is organoids.

So these are these kind of mini retinas in a dish, uh, that recapitulate our own retinas.

So they have, you know, the layers, they have the different cell types.

What current research or studies are you really excited about right now that you're working on?